cover image - Pain Management Secrets - Elsevier E-Book on VitalSource, 4th Edition
ISBN: 9780443550157
Copyright: 2019
Publication Date: 04-14-2026
Page Count: 384
Imprint: Elsevier
List Price: $41.99

Pain Management Secrets - Elsevier E-Book on VitalSource, 4th Edition

by Charles E. Argoff, MD, Andrew Dubin, MD, MS and Julie Pilitsis, MD, PhD

Elsevier eBook on VitalSource

cover image - Pain Management Secrets - Elsevier E-Book on VitalSource, 4th Edition
ISBN: 9780443550157
Copyright: 2019
Publication Date: 04-14-2026
Page Count: 384
Imprint: Elsevier
List Price: $41.99
Was $41.99

Now $37.79

Or $0.00 with a valid access code

For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Pain Management Secrets, 4th Edition, features the Secrets’ popular question-and-answer format that also includes lists, tables, and an easy-to-read style – making reference and review quick, easy, and enjoyable.

    • The proven Secrets Series® format gives you the most return for your time – concise, easy to read, engaging, and highly effective
    • Covers the full range of essential topics in pain management for in-training or practicing professionals
    • Top 100 Secrets and Key Points boxes provide a fast overview of the secrets you must know for success in practice and on exams
    • Portable size makes it easy to carry with you for quick reference or review anywhere, anytime
  • I. OVERVIEW
    1. Definitions, Ronald Kanner, MD
    2. Classification of Pain, Robert A. Duarte, MD
    3. Basic Mechanisms, Allan Basbaum, PhD
    4. Topiceuticals, Charles E. Argoff, MD

    II. CLINICAL APPROACH
    5. History Taking in the Patient with Pain, Howard S. Smith, MD and Andrew Dubin, MD
    6. Physical Examination of the Patient with Pain, Howard S. Smith, MD and Andrew Dubin, MD, MS
    7. Pain Measurement, W. Cranford Clark, PhD, Sita S. Chokhavatia, MD, Abbas Kashani, MD, and Susanne Bennett Clark, PhD
    8. Psychological Assessment of Chronic Patients, Dennis Thornton, PhD

    III. CLINICAL SYNDROMES DEFINED BY PAIN
    9. Neuroimaging in the Patient with Pain, Howard S. Smith, MD
    10. Tension-Type Headache, Richard B. Lipton, MD, and Lawrence C. Newman, MD
    11. Migraine, Richard B. Lipton, MD, and Lawrence C. Newman, MD
    12. Cluster Headache, Lawrence C. Newman, MD, and Richard B. Lipton, MD
    13. The Paroxysmal Hemicranias, Lawrence C. Newman, MD, and Richard B. Lipton, MD
    14. Subarachnoid Hemorrhage, Ronald Kanner, MD
    15. Brain Tumor Headaches, Ronald Kanner, MD
    16. Increased and Decreased Intracranial Pressure, Ronald Kanner, MD
    17. Temporal Giant Cell Arteritis, Robert A. Duarte, MD
    18. Headaches Associated with Systemic Disease, Robert A, Duarte, MD
    19. Trigeminal Neuralgia, Robert A. Duarte, MD
    20. Glossopharyngeal and Other Facial Neuralgias, Robert A. Duarte, MD
    21. Low Back Pain, Ronald Kanner, MD
    22. Neck and Arm Pain, Ronald Kanner, MD and Gary McCleane, MD
    23. Abdominal Pain, Ronald E. Greenberg MD
    24. Chronic Pelvic Pain, Helen Greco, MD
    25. Fibromyalgia and Myofascial Pain, Mark Thomas, MD, and Ronald Kanner, MD

    IV. SYNDROMES IN WHICH PAIN IS A SIGNIFICANT COMPONENT
    26. Postoperative Pain Management, Michael Hanania, MD
    27. Cancer Pain Syndrome, Gilbert R. Gonzales, MD
    28. Pain in Rheumatoid Arthritis and Osteoarthritis, David S. Pisetsky, MD, PhD and Gary McCleane, MD
    29. Neuropathic Pain, Russell K. Portenoy, MD and Ricardo Cruciani, MD, PhD

    V. PSYCHOLOGICAL SYNDROMES
    30. Psychological Syndromes, Dennis Thornton, PhD

    VI. SPECIAL PATIENT POPULATIONS
    31. Pain in Children, Patricia A. McGrath, PhD, and Stephen C. Brown, MD
    32. Pain in the Older Patient, Ronald Kanner, MD

    VII. PHARMACOLOGIC MANAGEMENT
    33. Nonsteroidal Anti-inflammatory Drugs, Robert A. Duarte, MD
    34. Opioid Analgesics, Ronald Kanner, MD
    35. Addiction and Pain Management, Robert Kanner, MD
    36. Regulatory Issues, Ellen Cooper, MS
    37. Adjuvant Analgesics, Brian Thiessen, MD, and Russell K. Portenoy, MD

    VIII. NONPHARMOLOGIC MANAGEMENT
    38. Temporary Neural Blockade, Michael Hanania, MD, and Martin R. Boorin, MD
    39. Permanent Neural Blockade and Chemical Ablation, Michael Hanania, MD
    40. Sympathetic Neural Blockade, Meir Chernofsky, MD, and Michael Hanania, MD
    41. Intraspinal Opioids, Zahid H. Bajwa, MD, Stephen A. Cohen, MD, Carol A. Warfield, MD, and Gary McCleane
    42. Neurostimulatory and Neuorablative Pocedures, Jason E. Silvers, BS, and James N. Campbell, MD
    43. Psychological Constructs and Treatment Interventions, Dennis Thornton, PhD
    44. Physiatric Modalities in Pain Management, Mark A. Thomas, MD
    45. Physical Modalities: Adjunctive Treatments to Reduce Pain and Maximize Function, Bryan J. O'Young MD, Mark A. Young MD, Jeffrey S. Meyers, MD, Steven A. Stiens, MD
    46. Pain Clinics, Nelson Hendler, MD, MS
    47. Interventional Pain Management, Charles E. Argoff, MD and Gary McCleane, MD
    48. Complementary and Alternative Medicine, Robert A. Duarte, MD
  • Charles E. Argoff, MD, Professor of Neurology, Director, Comprehensive Pain Management Center, Albany Medical College, Albany, NY, USA, Andrew Dubin, MD, MS, Professor of PM&R, Albany Medical College, Department of PM&R, Albany New York and Julie Pilitsis, MD, PhD, Professor, Albany Medical College, Department of Neurosurgery; Chair and Professor, Albany Medical College, Department of Neuroscience and Experimental Therapeutics, Albany New York, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
    • Conformance
      • The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
      • For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
      • For queries regarding accessibility information, contact [email protected]
      • The publication was certified on 09-04-2026
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $41.99

Now $37.79

Or $0.00 with a valid access code